PORT updated treatment recommendations

Schizophrenia Bulletin

Volumn 30, Issue 3, 2004, Pages 617-618

  Torrey, E Fuller ^a  

^a Stanley Medical Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

BODY WEIGHT DISORDER; DETERIORATION; DRUG EFFICACY; HOMELESSNESS; HUMAN; HUMAN RIGHTS; HYPERGLYCEMIA; MENTAL HEALTH SERVICE; NOTE; PRIORITY JOURNAL; SCHIZOPHRENIA; SIDE EFFECT; STARVATION; TREATMENT INDICATION; UNITED STATES;

EID: 10344249958     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a007108     Document Type: Note

References (5)

1. Kessler, R.C.; Berglund, P.A.; Bruce, M.L.; Koch, J.R.; Laska, E.M.; Leaf, P.J.; Manderscheid, R.W.; Rosenheck, R.A.; Walters, E.E.; and Wang, P.S. The prevalence and correlates of untreated serious mental illness. Health Services Research, 36:987-1007, 2001.
2. Lehman, A.F.; Kreyenbuhl, J.; Buchanan, R.W.; Dickerson, F.B.; Dixon, L.B.; Goldberg, R.; Green-Paden, L.D.; Tenhula, W.N.; Boerescu, D.; Tek, C.; Sandson, N.; and Steinwachs, D.M. The Schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2003. Schizophrenia Bulletin, 30(2): 193-217, 2004.
3. National Advisory Mental Health Council. Health care reform for Americans with severe mental illnesses: Report of the National Advisory Mental Health Council. American Journal of Psychiatry, 150(10):1447-1465, 1993.
4. Torrey, E.F. Continuous treatment teams in the care of the chronic mentally ill. Hospital and Community Psychiatry, 37(12):1243-1247, 1986.
5. Treffert, D.A. Editorial. 1995 Wisconsin Act 292: Finally, the fifth standard. Wisconsin Medical Journal, 95:537-540, 1996.